Hematology & Blood Research
Executive Overview Acute lymphoblastic leukemia (ALL) remains the most prevalent pediatric malignancy globally, yet a profound geopolitical divide continues to...
8 Aug 2026
Hematology & Blood Research
Executive Overview Acute promyelocytic leukemia (APL) has long been considered one of the great success stories of modern hematology, with...
7 Aug 2026
Hematology & Blood Research
Executive Overview For more than half a century, cytotoxic chemotherapy has achieved a monumental milestone in modern medicine: the routine,...
7 Aug 2026
Hematology & Blood Research
Executive Overview For decades, disease relapse following an allogeneic hematopoietic cell transplantation (allo-HCT)—the high-stakes curative procedure for acute leukemias and...
7 Aug 2026
Hematology & Blood Research
Executive Overview When a patient receives a leukaemia diagnosis, the shockwaves instantly reverberate far beyond hospital walls, profoundly altering the...
7 Aug 2026
Hematology & Blood Research
In a rare and clinically complex case highlighting the hidden dangers of cancer-associated coagulopathy, medical specialists at Padua University Hospital...
6 Aug 2026
Hematology & Blood Research
Executive Overview Acute Myeloid Leukemia (AML) is one of the most aggressive and complex malignancies of the human hematopoietic system....
6 Aug 2026
Hematology & Blood Research
Executive Overview Red blood cells (RBCs) rely entirely on glycolysis to sustain their structural integrity, membrane flexibility, and essential physiological...
7 Jul 2026